secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vireo Growth Inc. (VREOF)
CIK:        0001771706
Form:       8-K
Filed at:   2022-12-08T23:59:59+00:00
Accession:  0001104659-22-125534
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Goodness Growth appoints Josh Rosen as Interim President with $300K salary, 2M options
--------------------------------------------------------------------------------

- Josh Rosen appointed Interim President of Goodness Growth and Vireo Health, effective Dec 5, 2022.
- Base compensation $300K/year (40% deferred); option to purchase 2M subordinate voting shares, 500K vested immediately.
- C-suite to report to Rosen; Dr. Kingsley remains CEO focusing on strategy, government relations, and medical cannabis.
- Rosen previously a board member since Aug 2021; also Managing Partner of Bengal Capital and former CEO of 4Front Ventures.
- Appointment follows termination of planned merger with Verano; Rosen to focus on operational efficiencies and adult-use markets.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1771706/000110465922125534/0001104659-22-125534-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1771706/000110465922125534/tm2232306d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-125534

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer